BRIEF-FDA's Woodcock Says Will Review Pfizer's Request To Amend EUA To Expand Age Range For Its COVID19 Vaccine To Include Indi
BRIEF-FDA's Woodcock Says Will Review Pfizer's Request To Amend EUA To Expand Age Range For Its COVID19 Vaccine To Include Indi
Brief-FDA的Woodcock表示,将审查辉瑞修改EUA的请求,以扩大其COVID19疫苗的年龄范围,将INDI包括在内
April 9 (Reuters) -
* FDA'S WOODCOCK-WILL REVIEW PFIZER'S REQUEST TO AMEND EUA TO EXPAND AGE RANGE FOR ITS COVID19 VACCINE TO INCLUDE INDIVIDUALS 12-15 YEARS OF AGE -TWEET
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* FDA'S WOODCOCK-WILL REVIEW PFIZER'S REQUEST TO AMEND EUA TO EXPAND AGE RANGE FOR ITS COVID19 VACCINE TO INCLUDE INDIVIDUALS 12-15 YEARS OF AGE -TWEET
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
April 9 (Reuters) -
* FDA'S WOODCOCK-WILL REVIEW PFIZER'S REQUEST TO AMEND EUA TO EXPAND AGE RANGE FOR ITS COVID19 VACCINE TO INCLUDE INDIVIDUALS 12-15 YEARS OF AGE -TWEET
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透4月9日电-*FDA的Woodcock-将审查辉瑞修改EUA的请求,以扩大其COVID19疫苗的年龄范围,将12-15岁的个人包括在内-推特源文本:进一步的公司报道:(Reurs.Briefs@thomsonreurs.com;)
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
风险及免责提示
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
知道了
风险及免责提示
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!